Versant Ventures VI GP, L.P., 10% Owner at LENZ Therapeutics, Inc. (LENZ), sold 435,678 shares at $30.35 ($13.2M) on 2025-06-20, disclosed to the SEC on 2025-06-20.
Open-market sale of $13.2M LENZ by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.95 | 100,000 | $3.0M | 22.7% |
| 2 | $30.25 | 133,924 | $4.1M | 30.8% |
| 3 | $30.35 | 100,877 | $3.1M | 23.2% |
| 4 | $30.35 | 100,877 | $3.1M | 23.2% |
| Total | $30.23 avg | 435,678 | $13.2M | 100% |
| Filing → |
| AKRO | SELL | 2020-07-10 | $2.1M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |